Quanterix Corp
QTRX5.969USD
+0.109+1.86%
交易中 （美東）報價延遲15分鐘
231.60M總市值
虧損本益比TTM
關於 Quanterix Corp 公司
Quanterix Corporation 是一家生命科學公司。該公司致力於開發超靈敏數字免疫測定平臺，以促進生命科學研究和診斷的精準健康。其平臺基於其數字 Simoa 檢測技術。其 Simoa 珠狀和平面陣列平臺使客戶能夠檢測血液、血清和其他液體中低濃度的蛋白質生物標誌物。該公司的 Simoa 技術基於傳統的酶聯免疫吸附測定 (ELISA) 技術。其產品包括 HD-X、SR-X、SP-X、Simoa 測定和耗材以及 NfL 抗體和 NfL ELISA 試劑盒。它還通過其加速器實驗室爲客戶提供合同研究服務，該實驗室爲客戶提供 Simoa 技術，並支持多個項目和服務，包括樣品測試、自制測定開發和定製測定開發。它已經使用其 Simoa 平臺爲 480 個客戶完成了 2,200 多個項目。
公司簡介
公司代碼QTRX
公司名稱Quanterix Corp
上市日期Dec 07, 2017
CEODr. Masoud Toloue, Ph.D.
員工數量471
證券類型Ordinary Share
年結日Dec 07
公司地址900 Middlesex Turnpike
城市BILLERICA
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編01821
電話16173019400
網址https://www.quanterix.com/
公司代碼QTRX
上市日期Dec 07, 2017
CEODr. Masoud Toloue, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. David R. Walt, Ph.D.
Dr. David R. Walt, Ph.D.
Independent Director
Independent Director
1.86M
+0.12%
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
278.40K
-0.44%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Independent Chairman of the Board
Independent Chairman of the Board
130.34K
+3.33%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
28.65K
--
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
27.40K
--
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
26.41K
+20.04%
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Independent Director
Independent Director
19.42K
+62.04%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
9.28K
-2.41%
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Paul M. Meister
Mr. Paul M. Meister
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. David R. Walt, Ph.D.
Dr. David R. Walt, Ph.D.
Independent Director
Independent Director
1.86M
+0.12%
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
278.40K
-0.44%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Independent Chairman of the Board
Independent Chairman of the Board
130.34K
+3.33%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
28.65K
--
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
27.40K
--
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
26.41K
+20.04%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Product revenue
20.74M
68.51%
Service and other revenue
8.76M
28.95%
Collaboration and license revenue
771.00K
2.55%
地區USD
名稱
營收
佔比
North America
19.38M
64.01%
EMEA
6.63M
21.92%
Asia Pacific
4.26M
14.07%
業務
地區
業務USD
名稱
營收
佔比
Product revenue
20.74M
68.51%
Service and other revenue
8.76M
28.95%
Collaboration and license revenue
771.00K
2.55%
股東統計
更新時間: 8月2日 週六
更新時間: 8月2日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Columbia Threadneedle Investments (UK)
6.49%
Portolan Capital Management, L.L.C.
6.41%
BlackRock Institutional Trust Company, N.A.
5.81%
The Vanguard Group, Inc.
5.47%
Kent Lake PR LLC
4.52%
Other
71.29%
持股股東
持股股東
佔比
Columbia Threadneedle Investments (UK)
6.49%
Portolan Capital Management, L.L.C.
6.41%
BlackRock Institutional Trust Company, N.A.
5.81%
The Vanguard Group, Inc.
5.47%
Kent Lake PR LLC
4.52%
Other
71.29%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
30.87%
Investment Advisor
25.39%
Hedge Fund
12.76%
Individual Investor
6.60%
Research Firm
3.49%
Pension Fund
0.35%
Bank and Trust
0.21%
Family Office
0.13%
Venture Capital
0.05%
Other
20.15%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
391
37.62M
83.70%
-11.91M
2025Q1
401
40.45M
104.19%
-6.42M
2024Q4
388
38.02M
98.63%
-6.28M
2024Q3
386
36.47M
95.03%
-5.94M
2024Q2
394
35.66M
93.20%
-9.57M
2024Q1
395
35.56M
93.43%
-9.17M
2023Q4
388
34.77M
91.99%
-10.35M
2023Q3
382
36.53M
97.35%
-9.84M
2023Q2
388
36.74M
98.24%
-9.95M
2023Q1
389
37.25M
100.03%
-8.36M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Columbia Threadneedle Investments (UK)
3.00M
7.72%
+237.57K
+8.60%
Mar 31, 2025
Portolan Capital Management, L.L.C.
2.96M
7.63%
+375.57K
+14.51%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.68M
6.91%
-89.03K
-3.21%
Mar 31, 2025
The Vanguard Group, Inc.
2.53M
6.5%
+316.41K
+14.32%
Mar 31, 2025
Kent Lake PR LLC
2.92M
7.53%
+279.82K
+10.58%
Mar 31, 2025
Walt (David R)
1.86M
4.79%
+370.00K
+24.84%
Jun 13, 2025
William Blair Investment Management, LLC
1.11M
2.85%
+43.96K
+4.14%
Mar 31, 2025
UBS Financial Services, Inc.
1.11M
2.87%
+186.90K
+20.14%
Mar 31, 2025
Easterly Investment Partners LLC
1.33M
3.41%
+370.63K
+38.81%
Mar 31, 2025
Invenomic Capital Management LP
902.04K
2.32%
+546.67K
+153.83%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
0.58%
iShares Micro-Cap ETF
0.06%
Fidelity Enhanced Small Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.03%
iShares Biotechnology ETF
0.02%
iShares Russell 2000 Value ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
Schwab U.S. Small-Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比0.58%
iShares Micro-Cap ETF
佔比0.06%
Fidelity Enhanced Small Cap ETF
佔比0.04%
Avantis US Small Cap Equity ETF
佔比0.03%
iShares Biotechnology ETF
佔比0.02%
iShares Russell 2000 Value ETF
佔比0.02%
Invesco RAFI US 1500 Small-Mid ETF
佔比0.02%
Schwab U.S. Small-Cap ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
